The Jan. 31 report indicated that 48% of adults associate consistent use of low-dose aspirin with reducing the risk of heart ...
Nearly half of U.S. adults still believe that the benefits of taking low-dose aspirin daily outweighs the risks — despite new ...
Many Americans don't see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks ...
Many Americans don’t see anything wrong with taking daily low-dose aspirin, even though experts have concluded its ris ...
For years, healthy older adults were advised by doctors to take a low-dose aspirin daily as a way to reduce the risk of heart ...
Daily, low-dose aspirin is no longer recommended for the prevention of stroke and heart attack in older adults not at higher ...
Copyright 2025 The Associated Press. All Rights Reserved. Leverkusen’s head coach Xabi Alonso looks on ahead of the German Bundesliga soccer match between Borussia ...
Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.
Bayer’s Monsanto unit stopped making toxic polychlorinated biphenyls (PCBs) a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are ...
Bayer AG’s Monsanto unit stopped making toxic PCBs a half century ago, but the legal fallout lingers even as many of the building materials made with the chemicals are no longer used in US homes ...
Trial was the latest over harm tied to school outside Seattle Company vows appeal of verdict and ‘excessive’ damages awarded Bayer AG was told by a jury to pay $100 million to four people at a Seattle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results